| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 12/10/2009 | US20090304754 Pegylated glutenase polypeptides |
| 12/10/2009 | US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions |
| 12/10/2009 | US20090304699 Methods of treating fibrosis |
| 12/10/2009 | US20090304671 Method of treating endothelial dysfunction |
| 12/10/2009 | CA2726917A1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 12/10/2009 | CA2726885A1 Sirna of human osteopontin |
| 12/10/2009 | CA2726644A1 Pharmaceutical combination |
| 12/10/2009 | CA2726244A1 Dpp-iv inhibitors for use in the treatment of nafld |
| 12/10/2009 | CA2726193A1 Methods of treating inflammatory intestinal disease and managing symptoms thereof |
| 12/10/2009 | CA2722780A1 Sweet containing algae for the prevention of oro-dental infections |
| 12/09/2009 | EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 12/09/2009 | EP2130830A1 Muscarinic receptor antagonists |
| 12/09/2009 | EP2130548A2 Growth Hormone Releasing Peptides |
| 12/09/2009 | EP2130547A1 IL-25 for use in the treatment of inflammatory diseases |
| 12/09/2009 | EP2130543A1 Method for decreasing borborygmi by administering a bifidobacterium bacteria |
| 12/09/2009 | EP2130537A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/09/2009 | EP2130536A1 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 12/09/2009 | EP2129775A1 Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
| 12/09/2009 | EP2129663A2 Muscarinic receptor antagonists |
| 12/09/2009 | EP2129216A1 Production of a viable, storable worm egg suspension |
| 12/09/2009 | EP1554256B1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/09/2009 | EP1519939B1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 12/09/2009 | EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 12/09/2009 | EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors |
| 12/09/2009 | CN101600724A Nk1 receptor antagonist composition |
| 12/09/2009 | CN101600717A 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives |
| 12/09/2009 | CN101600452A Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 12/09/2009 | CN101600426A Isosorbide mononitrate derivatives for the treatment of intestinal disorders |
| 12/09/2009 | CN101597606A SiRNA sequence aiming at protein gene like TRAP-1 and application thereof |
| 12/09/2009 | CN101597260A Novel muscarinic receptor antagonist and application thereof |
| 12/09/2009 | CN101597212A Kirenol derivative and application thereof in preparation of proinflammatory cytokine inhibitor |
| 12/09/2009 | CN101597192A Chinese medicinal herb culture medium, preparation method thereof and cultivation method of edible fungus |
| 12/09/2009 | CN101596314A Mixed-fat polypeptide vaccine for preventing and treating viral hepatitis C |
| 12/09/2009 | CN101596310A Artificial substrate membrane emulsifying paste for wound surface restoration |
| 12/09/2009 | CN101596304A Traditional Chinese drug medicament for curing chronic diarrheal disease |
| 12/09/2009 | CN101596299A Traditional Chinese medicine pill for treating precancerous lesions of chronic atrophic gastritis |
| 12/09/2009 | CN101596296A Method for controlling quality of infant antidiarrheal granules |
| 12/09/2009 | CN101596269A Method for controlling quality of infant spleen tonifyning granules |
| 12/09/2009 | CN101596267A Chinese medicinal composition for treating intestinal diseases and preparation method and application thereof |
| 12/09/2009 | CN101596265A Traditional Chinese medicine compound preparation for enhancing body fatigue resistance |
| 12/09/2009 | CN101596262A Medicine for treating habit constipation and preparation method thereof |
| 12/09/2009 | CN101596259A Medicine for treating cirrhosis and preparation method thereof |
| 12/09/2009 | CN101596249A Chinese medicinal composition and Chinese medicament for treating diarrhea and preparation method thereof |
| 12/09/2009 | CN101596236A Paste for treating toothache |
| 12/09/2009 | CN101596230A Medicinal composition for treating hepatopathy |
| 12/09/2009 | CN101596229A Pithecellobium clypearia extractive and quality control method of preparation thereof |
| 12/09/2009 | CN101596224A New application of penthorum chinense pursh extract |
| 12/09/2009 | CN101596223A Method for enriching ginkgetin compound |
| 12/09/2009 | CN101596208A Medicine composition for treating burns, scalds, tympanitis and ulceratiue stomatitis |
| 12/09/2009 | CN101596202A Application of tanshinone IIA emulsion on treating liver diseases |
| 12/09/2009 | CN101596196A Ligustrazine and danshensu composition and pharmacology activity research |
| 12/09/2009 | CN101596179A Medicament composition for treating hyperammonemia and preparation method thereof |
| 12/09/2009 | CN101596170A Trospium chloride slow-release tablet |
| 12/09/2009 | CN101596165A Pantoprazole sodium enteric-coated pellet |
| 12/09/2009 | CN101596160A Alpha-asarone mixed micelle injectio and preparation method thereof |
| 12/09/2009 | CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof |
| 12/09/2009 | CN100567266C Cannabinoid receptor ligands |
| 12/09/2009 | CN100566739C Composition containing radix notoginseng, eucommia and american ginseng |
| 12/09/2009 | CN100566729C Chinese medicine for treating hepatic fibrosis |
| 12/09/2009 | CN100566724C Middle gut positioning sausage dissolvable pharmaceutical formulations for relieving diarrhea and processes for their preparation |
| 12/09/2009 | CN100566703C Plaster for promoting peristalsis and urination after operation |
| 12/09/2009 | CN100566599C Method for preparing sweet potato meal fiber tablets |
| 12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 12/08/2009 | US7629369 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 12/08/2009 | US7629368 Nitroderivatives as drugs for diseases having an inflammatory basis |
| 12/08/2009 | US7629363 Diaryl substituted pyridinones |
| 12/08/2009 | US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/08/2009 | US7629341 Human ADAM-10 inhibitors |
| 12/08/2009 | US7629337 Chemokine receptor binding heterocyclic compounds |
| 12/08/2009 | US7629318 Immunosuppressant compounds, methods and uses related thereto |
| 12/08/2009 | US7629155 foods and beverages containing 1,4-dihydroxy-2-naphthalene carboxylic acid or salts, used for improving intestinal flora, alleviating abdominal ailments caused by lactose intolerance and for preventing or treating metabolic bone diseases |
| 12/08/2009 | US7629144 Diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with Secs-1 polypeptides |
| 12/08/2009 | US7628991 Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies |
| 12/08/2009 | US7628988 Induce cell differentiation; process control |
| 12/08/2009 | US7628981 Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 12/08/2009 | CA2482311C Furyl compounds |
| 12/08/2009 | CA2422354C Pyrazole compounds useful as protein kinase inhibitors |
| 12/08/2009 | CA2419301C Quinazoline derivatives |
| 12/08/2009 | CA2404005C Composition comprising free amino acids |
| 12/08/2009 | CA2322865C Pharmaceutical compositions for ulcer |
| 12/08/2009 | CA2315113C Pyridones as src family sh2 domain inhibitors |
| 12/08/2009 | CA2314613C Azolo triazines and pyrimidines |
| 12/03/2009 | WO2009146123A2 Compositions and methods for treating viral infections |
| 12/03/2009 | WO2009145716A1 New pharmaceutical formulation useful in gerd therapy |
| 12/03/2009 | WO2009145238A1 Immunomodulatory agent and use thereof |
| 12/03/2009 | WO2009144555A1 Pyrazolospiroketone acetyl-coa carboxylase inhibitors |
| 12/03/2009 | WO2009144554A1 Pyrazolospiroketone acetyl-c0a carboxylase inhibitors |
| 12/03/2009 | WO2009144137A1 Probiotics to improve gut microbiota |
| 12/03/2009 | WO2009144093A1 Hydroxytyrosol benefits mitochondria |
| 12/03/2009 | WO2009144038A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
| 12/03/2009 | WO2009143864A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases |
| 12/03/2009 | WO2009143572A1 Methods of treating mammals with eustachian tube dysfunctions |
| 12/03/2009 | WO2009117987A3 Use of boswellia acids and synthetic boswellia acid derivatives for inhibiting microsomal prostanglandin e2 synthase and cathepsin g |
| 12/03/2009 | WO2009100456A3 Inhibition and treatment of gastrointestinal biofilms |
| 12/03/2009 | WO2009100275A3 Compositions and devices |
| 12/03/2009 | WO2009100272A3 Effervescent compositions |
| 12/03/2009 | WO2009024677A3 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection |
| 12/03/2009 | US20090298948 Colchicine compositions and methods |
| 12/03/2009 | US20090298929 Novel natural cyclodextrin complexes |
| 12/03/2009 | US20090298884 Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same |